BSE Live
Dec 31, 16:01Prev. Close
388.45
Open Price
388.75
Bid Price (Qty.)
376.25 (420)
Offer Price (Qty.)
379.95 (11)
NSE Live
Dec 31, 15:59Prev. Close
386.55
Open Price
388.00
Bid Price (Qty.)
376.30 (1480)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Panacea Biotec (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 892.05 | 779.49 | 837.00 | 842.95 | 548.69 | |
| Less: Excise/Sevice Tax/Other Levies | 0.80 | 1.88 | 3.78 | 8.45 | 11.62 | |
| Revenue From Operations [Net] | 891.25 | 777.61 | 833.23 | 834.50 | 537.07 | |
| Total Operating Revenues | 891.25 | 777.61 | 833.23 | 834.50 | 537.07 | |
| Other Income | 71.92 | -50.82 | 18.03 | 26.46 | 5.98 | |
| Total Revenue | 963.17 | 726.79 | 851.25 | 860.95 | 543.05 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 520.89 | 312.21 | 360.66 | 377.67 | 272.36 | |
| Purchase Of Stock-In Trade | 18.01 | 15.59 | 17.30 | 10.03 | 2.04 | |
| Operating And Direct Expenses | 5.65 | 7.96 | 4.45 | 4.54 | 4.19 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -51.48 | -44.69 | 2.18 | 11.76 | 0.30 | |
| Employee Benefit Expenses | 99.02 | 91.61 | 92.49 | 78.80 | 42.97 | |
| Finance Costs | 38.27 | 32.11 | 11.63 | 15.22 | 11.82 | |
| Depreciation And Amortisation Expenses | 48.86 | 53.61 | 29.87 | 24.52 | 13.92 | |
| Other Expenses | 165.50 | 350.51 | 154.35 | 129.29 | 94.94 | |
| Total Expenses | 844.89 | 819.07 | 673.10 | 652.09 | 443.01 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 118.28 | -92.28 | 178.15 | 208.87 | 100.04 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 118.28 | -92.28 | 178.15 | 208.87 | 100.04 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.48 | 0.00 | 33.00 | 46.30 | 25.50 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 37.51 | -26.12 | 21.12 | 13.70 | 11.17 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 38.19 | -23.23 | 57.30 | 62.29 | 39.24 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 80.09 | -69.05 | 120.85 | 146.58 | 60.80 | |
| Profit/Loss From Continuing Operations | 80.02 | -69.05 | 133.17 | 146.81 | 60.94 | |
| Profit/Loss For The Period | 80.02 | -69.05 | 133.17 | 146.81 | 60.94 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 11.97 | -10.34 | 19.94 | 22.32 | 10.66 | |
| Diluted EPS (Rs.) | 11.97 | -10.34 | 19.94 | 22.32 | 10.66 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 416.91 | 236.61 | 300.35 | 310.44 | 42.84 | |
| Indigenous Raw Materials | 86.89 | 60.55 | 49.31 | 54.61 | 224.42 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 3.71 | 2.86 | 1.94 | 2.32 | 0.00 | |
| Indigenous Stores And Spares | 16.88 | 16.35 | 11.80 | 13.73 | 7.02 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 1.67 | 0.00 | 6.67 | 6.57 | 5.71 | |
| Tax On Dividend | 0.28 | 0.00 | 1.13 | 1.40 | 1.37 | |
| Equity Dividend Rate (%) | 25.00 | 0.00 | 100.00 | 100.00 | 100.00 |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y